Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanying Du

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
Development of subunit vaccines against severe acute respiratory syndromeLanying Du, Yuxian He, Shibo Jiang, et al.
Vaccines|May 31, 2020
The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant FormulationParakkal Jovvian George, Wanbo Tai, Lanying Du, et al.
The Journal of Infection|December 26, 2012
A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMCShibo Jiang, Lu Lu, Lanying Du, et al.
The Journal of Infection|April 23, 2013
Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4Shibo Jiang, Lu Lu, Lanying Du, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 21, 2021
Advances in mRNA and other vaccines against MERS-CoVWanbo Tai, Xiujuan Zhang, Yang Yang, et al.
Antiviral Research|May 15, 2020
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2Wanbo Tai, Xiujuan Zhang, Yuxian He, et al.
Expert Review of Vaccines|August 27, 2020
An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studiesNaru Zhang, Jian Shang, Chaoqun Li, et al.
Viruses|January 17, 2019
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding DomainYusen Zhou, Yang Yang, Jingwei Huang, et al.
Virus Research|December 3, 2014
Receptor-binding domain-based subunit vaccines against MERS-CoVNaru Zhang, Jian Tang, Lu Lu, et al.
Vaccines|January 28, 2026
Omicron KP.3 RBD-Containing Spike mRNA Vaccine Induces Broadly Neutralizing Antibodies with Protection Against SARS-CoV-2 Omicron Infection in MiceXiaoqing Guan, Hansam Cho, Shengnan Qian, et al.
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
Development of subunit vaccines against severe acute respiratory syndromeLanying Du, Yuxian He, Shibo Jiang, et al.
Vaccines|May 31, 2020
The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant FormulationParakkal Jovvian George, Wanbo Tai, Lanying Du, et al.
The Journal of Infection|December 26, 2012
A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMCShibo Jiang, Lu Lu, Lanying Du, et al.
The Journal of Infection|April 23, 2013
Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4Shibo Jiang, Lu Lu, Lanying Du, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 21, 2021
Advances in mRNA and other vaccines against MERS-CoVWanbo Tai, Xiujuan Zhang, Yang Yang, et al.
Antiviral Research|May 15, 2020
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2Wanbo Tai, Xiujuan Zhang, Yuxian He, et al.
Expert Review of Vaccines|August 27, 2020
An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studiesNaru Zhang, Jian Shang, Chaoqun Li, et al.
Viruses|January 17, 2019
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding DomainYusen Zhou, Yang Yang, Jingwei Huang, et al.
Virus Research|December 3, 2014
Receptor-binding domain-based subunit vaccines against MERS-CoVNaru Zhang, Jian Tang, Lu Lu, et al.
Vaccines|January 28, 2026
Omicron KP.3 RBD-Containing Spike mRNA Vaccine Induces Broadly Neutralizing Antibodies with Protection Against SARS-CoV-2 Omicron Infection in MiceXiaoqing Guan, Hansam Cho, Shengnan Qian, et al.
Pageof 19